Curcumin causes the growth arrest and apoptosis of B cell lymphoma by downregulation of egr-1, C-myc, Bcl-XL, NF-κB, and p53

被引:175
作者
Han, SS
Chung, ST
Robertson, DA
Ranjan, D
Bondada, S
机构
[1] Univ Kentucky, Dept Microbiol & Immunol, Lexington, KY 40536 USA
[2] Univ Kentucky, Sanders Brown Res Ctr Aging, Lexington, KY 40536 USA
[3] Univ Kentucky, Dept Gen Surg, Transplantat Sect, Lexington, KY 40536 USA
[4] Korea Food & Drug Adm, Div Immunotoxicol, Seoul 122020, South Korea
关键词
D O I
10.1006/clim.1999.4769
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
It has been well known that curcumin is a powerful inhibitor of proliferation of several tumor cells. However, the molecular basis of the anti-proliferative effect of curcumin has not been investigated in detail. In this paper, we present evidence to show that curcumin inhibited proliferation of a variety of B lymphoma cells. At low concentrations curcumin inhibited the proliferation of BKS-2, an immature B cell lymphoma, more effectively than that of normal B lymphocytes and caused the apoptosis of BKS-2 cells in a dose- and time-dependent manner. Furthermore, curcumin downregulated the expression of survival genes egr-1, c-myc, and bcl-X-L as well as the tumor suppressor gene p53 in B cells. In addition, NF-kappa B binding activity was also downregulated almost completely by curcumin, Stimulation with CpG oligonucleotides or anti-CD40 overcame growth inhibition induced by low concentrations of curcumin, Our results suggest that curcumin caused the growth arrest and apoptosis of BKS-2 immature B cell lymphoma by downregulation of growth and survival promoting genes, (C) 1999 Academic Press.
引用
收藏
页码:152 / 161
页数:10
相关论文
共 52 条
[1]   ANTI-IGM INDUCES TRANSFORMING GROWTH-FACTOR-BETA SENSITIVITY IN A HUMAN B-LYMPHOMA CELL-LINE - INHIBITION OF GROWTH IS ASSOCIATED WITH A DOWN-REGULATION OF MUTANT P53 [J].
BECKWITH, M ;
RUSCETTI, FW ;
SING, GK ;
URBA, WJ ;
LONGO, DL .
BLOOD, 1995, 85 (09) :2461-2470
[2]  
Bierhaus A, 1997, THROMB HAEMOSTASIS, V77, P772
[3]  
Carman JA, 1996, J IMMUNOL, V156, P4562
[4]  
Chen XG, 1997, ANTICANCER RES, V17, P2555
[5]   MONOCLONALITY OF LYMPHOPROLIFERATIVE LESIONS IN CARDIAC-TRANSPLANT RECIPIENTS - CLONAL ANALYSIS BASED ON IMMUNOGLOBULIN-GENE REARRANGEMENTS [J].
CLEARY, ML ;
WARNKE, R ;
SKLAR, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (08) :477-482
[6]   Involvement of Egr-1/RelA synergy in distinguishing T cell activation from tumor necrosis factor-alpha-induced NF-kappa B1 transcription [J].
Cogswell, PC ;
Mayo, MW ;
Baldwin, AS .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (03) :491-497
[7]  
Dent C, 1993, TRANSCRIPTION FACTOR
[8]  
DUYAO MP, 1990, CURR TOP MICROBIOL, V166, P211
[9]   A NOVEL REPRESSION MODULE, AN EXTENSIVE ACTIVATION DOMAIN, AND A BIPARTITE NUCLEAR-LOCALIZATION SIGNAL DEFINED IN THE IMMEDIATE-EARLY TRANSCRIPTION FACTOR EGR-1 [J].
GASHLER, AL ;
SWAMINATHAN, S ;
SUKHATME, VP .
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (08) :4556-4571
[10]   APOPTOSIS IN B-LYMPHOCYTES - THE WEHI-231 PERSPECTIVE [J].
GOTTSCHALK, AR ;
QUINTANS, J .
IMMUNOLOGY AND CELL BIOLOGY, 1995, 73 (01) :8-16